These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 24140033

  • 1. Subcutaneous progesterone versus vaginal progesterone gel for luteal phase support in in vitro fertilization: a noninferiority randomized controlled study.
    Lockwood G, Griesinger G, Cometti B, 13 European Centers.
    Fertil Steril; 2014 Jan; 101(1):112-119.e3. PubMed ID: 24140033
    [Abstract] [Full Text] [Related]

  • 2. A randomized, controlled trial comparing the efficacy and safety of aqueous subcutaneous progesterone with vaginal progesterone for luteal phase support of in vitro fertilization.
    Baker VL, Jones CA, Doody K, Foulk R, Yee B, Adamson GD, Cometti B, DeVane G, Hubert G, Trevisan S, Hoehler F, Jones C, Soules M.
    Hum Reprod; 2014 Oct 10; 29(10):2212-20. PubMed ID: 25100106
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and tolerability of vaginal progesterone capsules (Utrogest 200) compared with progesterone gel (Crinone 8%) for luteal phase support during assisted reproduction.
    Kleinstein J, Luteal Phase Study Group.
    Fertil Steril; 2005 Jun 10; 83(6):1641-9. PubMed ID: 15950631
    [Abstract] [Full Text] [Related]

  • 4. Clinical use of aqueous subcutaneous progesterone compared with vaginal progesterone as luteal support in in vitro fertilization: A randomized controlled study in Taiwan.
    Kao TC, Tu YA, Yang PK, Huang CC, Yang JH, Chen SU, Chao KH.
    Taiwan J Obstet Gynecol; 2022 Sep 10; 61(5):863-867. PubMed ID: 36088057
    [Abstract] [Full Text] [Related]

  • 5. A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization.
    Tournaye H, Sukhikh GT, Kahler E, Griesinger G.
    Hum Reprod; 2017 May 01; 32(5):1019-1027. PubMed ID: 28333318
    [Abstract] [Full Text] [Related]

  • 6. Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial.
    Griesinger G, Blockeel C, Sukhikh GT, Patki A, Dhorepatil B, Yang DZ, Chen ZJ, Kahler E, Pexman-Fieth C, Tournaye H.
    Hum Reprod; 2018 Dec 01; 33(12):2212-2221. PubMed ID: 30304457
    [Abstract] [Full Text] [Related]

  • 7. Comparative study of the efficacy and tolerability of two vaginal progesterone formulations, Crinone 8% gel and Utrogestan capsules, used for luteal support.
    Simunic V, Tomic V, Tomic J, Nizic D.
    Fertil Steril; 2007 Jan 01; 87(1):83-7. PubMed ID: 17081536
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the efficacy of two vaginal progesterone formulations, Crinone 8% gel and Utrogestan capsules, used for luteal support in blastocyst stage embryo transfers.
    Wang LJ, Huang FJ, Kung FT, Lin PY, Chang SY, Lan KC.
    Taiwan J Obstet Gynecol; 2009 Dec 01; 48(4):375-9. PubMed ID: 20045758
    [Abstract] [Full Text] [Related]

  • 9. Endometrin for luteal phase support in a randomized, controlled, open-label, prospective in-vitro fertilization trial using a combination of Menopur and Bravelle for controlled ovarian hyperstimulation.
    Doody KJ, Schnell VL, Foulk RA, Miller CE, Kolb BA, Blake EJ, Yankov VI.
    Fertil Steril; 2009 Apr 01; 91(4):1012-7. PubMed ID: 18371963
    [Abstract] [Full Text] [Related]

  • 10. Intramuscular progesterone versus 8% Crinone vaginal gel for luteal phase support for day 3 cryopreserved embryo transfer.
    Kaser DJ, Ginsburg ES, Missmer SA, Correia KF, Racowsky C.
    Fertil Steril; 2012 Dec 01; 98(6):1464-9. PubMed ID: 22959457
    [Abstract] [Full Text] [Related]

  • 11. Oral dydrogesterone versus vaginal progesterone gel in the luteal phase support: randomized controlled trial.
    Tomic V, Tomic J, Klaic DZ, Kasum M, Kuna K.
    Eur J Obstet Gynecol Reprod Biol; 2015 Mar 01; 186():49-53. PubMed ID: 25622239
    [Abstract] [Full Text] [Related]

  • 12. A prospective randomized multicentre study comparing vaginal progesterone gel and vaginal micronized progesterone tablets for luteal support after in vitro fertilization/intracytoplasmic sperm injection.
    Bergh C, Lindenberg S, Nordic Crinone Study Group.
    Hum Reprod; 2012 Dec 01; 27(12):3467-73. PubMed ID: 23019296
    [Abstract] [Full Text] [Related]

  • 13. Vaginal (Crinone 8%) gel vs. intramuscular progesterone in oil for luteal phase support in in vitro fertilization: a large prospective trial.
    Silverberg KM, Vaughn TC, Hansard LJ, Burger NZ, Minter T.
    Fertil Steril; 2012 Feb 01; 97(2):344-8. PubMed ID: 22188983
    [Abstract] [Full Text] [Related]

  • 14. Efficacy, safety and tolerability of progesterone vaginal pessaries versus progesterone vaginal gel for luteal phase support after in vitro fertilisation: a randomised controlled trial.
    Saunders H, Khan C, D'Hooghe T, Magnúsdóttir TB, Klingmann I, Hrafnsdóttir S, vaginal progesterone luteal phase support post IVF study group.
    Hum Reprod; 2020 Feb 29; 35(2):355-363. PubMed ID: 32074281
    [Abstract] [Full Text] [Related]

  • 15. Vaginal use of micronized progesterone for luteal support.A randomized study comparing Utrogestan® and Crinone® 8.
    Michnova L, Dostal J, Kudela M, Hamal P, Langova K.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Mar 29; 161(1):86-91. PubMed ID: 28323291
    [Abstract] [Full Text] [Related]

  • 16. Patient experience in a randomized trial of a weekly progesterone vaginal ring versus a daily progesterone gel for luteal support after in vitro fertilization.
    Ginsburg ES, Jellerette-Nolan T, Daftary G, Du Y, Silverberg KM.
    Fertil Steril; 2018 Nov 29; 110(6):1101-1108.e3. PubMed ID: 30396554
    [Abstract] [Full Text] [Related]

  • 17. Use of Crinone vaginal progesterone gel for luteal support in in vitro fertilization cycles.
    Chantilis SJ, Zeitoun KM, Patel SI, Johns DA, Madziar VA, McIntire DD.
    Fertil Steril; 1999 Nov 29; 72(5):823-9. PubMed ID: 10560985
    [Abstract] [Full Text] [Related]

  • 18. Vitrified blastocyst transfer cycles with the use of only vaginal progesterone replacement with Endometrin have inferior ongoing pregnancy rates: results from the planned interim analysis of a three-arm randomized controlled noninferiority trial.
    Devine K, Richter KS, Widra EA, McKeeby JL.
    Fertil Steril; 2018 Feb 29; 109(2):266-275. PubMed ID: 29338855
    [Abstract] [Full Text] [Related]

  • 19. A randomized study comparing Crinone 8% and intramuscular progesterone supplementation in in vitro fertilization-embryo transfer cycles.
    Propst AM, Hill JA, Ginsburg ES, Hurwitz S, Politch J, Yanushpolsky EH.
    Fertil Steril; 2001 Dec 29; 76(6):1144-9. PubMed ID: 11730742
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.